![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Vocalis Health’s COVID-19 Screening Tool Gets CE Mark
Vocalis Health’s COVID-19 Screening Tool Gets CE Mark
![CE mark](https://www.fdanews.com/ext/resources/images/ce-mark.gif?t=1627682539&width=430)
February 18, 2021
Vocalis Health has received CE mark certification for VocalisCheck, a software-only product used to screen for COVID-19.
The software analyzes a 20-second recording of the patient’s voice that is converted into a spectrogram and compared with the voices of COVID-19 positive patients using artificial intelligence and deep learning techniques.
VocalisCheck can be accessed by smartphones and other devices. It is not meant to serve as a diagnostic tool, but rather as a screening tool that delivers a risk score to identify patients who may require additional diagnostic testing.
Upcoming Events
-
21Oct